Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7.

Hyun Suk Yang Mina Hur Kyeong Ryong Lee Hanah Kim Hahn Young Kim Jong Won Kim Mui Teng Chua Win Sen Kuan Horng Ruey Chua Chagriya Kitiyakara Phatthranit Phattharapornjaroen Anchalee Chittamma Thiyapha Werayachankul Vasundhara Raghavan Sanjeeva Herath Zoltan Huba Endre Andrea Rita Horvath Paola Antonini Salvatore Di Sommanull null

Published in: Annals of laboratory medicine (2021)

NephroCheck can predict both AKI development and short-term mortality in at-risk ED patients. NephroCheck would be a useful biomarker for early ruling-in or ruling-out of AKI in the ED.

Keyphrases

emergency department
acute kidney injury
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
cardiovascular events
risk factors
cardiovascular disease
coronary artery disease